NT-proBNP cardiac value in COVID-19: a focus on the paediatric population
Cardiology in the Young · 2024-05 · 34 (5) · 959-968
DOI: 10.1017/s1047951124000283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology in the Young, online erschienen am 26.03.2024. Verfasst von Bshara Sleem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: COVID-19, Natriuretic Peptide, Brain, Peptide Fragments, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
NT-proBNP is a peptide related to brain natriuretic peptide, a cardiac biomarker and a member of the natriuretic family of peptides. NT-proBNP has demonstrated its clinical utility in the assessment of a wide spectrum of cardiac manifestations. It is also considered a more precise diagnostic and prognostic cardiac biomarker than brain natriuretic peptide. With the appearance of the Severe Acute Respiratory Syndrome Coronavirus 2 virus and the subsequent COVID-19 pandemic, diagnosis of heart implications began to pose an increasing struggle for the physician. Echocardiography is considered a central means of evaluating cardiac disorders like heart failure, and it is considered a reliable method. However, other diagnostic methods are currently being explored, one of which involves the assessment of NT-proBNP levels. In the literature that involves the adult population, significant positive correlations were drawn between the levels of NT-proBNP and COVID-19 outcomes such as high severity and fatality. In the paediatric population, however, the literature is scarce, and most of the investigations assess NT-proBNP in the context of Multiple Inflammatory Syndrome in Children, where studies have shown that cohorts with this syndrome had elevated levels of NT-proBNP when compared to non-syndromic cohorts. Thus, more large-scale studies on existing COVID-19 data should be carried out in the paediatric population to further understand the prognostic and diagnostic roles of NT-proBNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Pediatric Department, Division of Pediatric Cardiology, American University of Beirut Medical Center, Beirut, Lebanon.
ORCID-Profile: Bshara Sleem, Rana Zareef, Fadi Bitar, Mariam Arabi
Zitieren
APA
Sleem, B., El Rassi, C., Zareef, R., Bitar, F., & Arabi, M. (2024). NT-proBNP cardiac value in COVID-19: a focus on the paediatric population. Cardiology in the Young, 34(5), 959-968. https://doi.org/10.1017/s1047951124000283
Vancouver
Sleem B, El Rassi C, Zareef R, Bitar F, Arabi M. NT-proBNP cardiac value in COVID-19: a focus on the paediatric population. Cardiology in the Young. 2024;34(5):959-968. doi:10.1017/s1047951124000283
BibTeX
@article{Sleem2024,
author = {Sleem, Bshara and El Rassi, Christophe and Zareef, Rana and Bitar, Fadi and Arabi, Mariam},
title = {NT-proBNP cardiac value in COVID-19: a focus on the paediatric population},
journal = {Cardiology in the Young},
year = {2024},
volume = {34},
number = {5},
pages = {959--968},
doi = {10.1017/s1047951124000283}
}
EUVIMED